Autobio Diagnostics Co., Ltd. (SHA:603658)
China flag China · Delayed Price · Currency is CNY
31.14
-0.99 (-3.08%)
Sep 11, 2026, 3:00 PM CST

Autobio Diagnostics Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
4,1394,1414,3894,3684,3663,686
Other Revenue
85.1785.1781.9876.0575.7679.82
4,2244,2264,4714,4444,4423,766
Revenue Growth
-2.32%-5.47%0.62%0.05%17.94%26.45%
Cost of Revenue
1,4311,5021,5821,6121,8441,545
Gross Profit
2,7932,7242,8892,8322,5972,221
Selling, General & Admin
1,0931,061953.05920.21857.11757.02
Research & Development
607.12555.12731.93656.13568.48480.96
Other Operating Expenses
59.6533.5-3.2528.0528.2413.73
Operating Expenses
1,7701,6621,7371,6261,4711,267
Operating Income
1,0231,0621,1521,2061,126954.28
Interest Expense
-13.96-13.96-22.28-24.54-21.23-12.68
Interest & Investment Income
74.05111.59112.84144.76135.09116.43
Currency Exchange Gain (Loss)
-1.6-1.60.631.197.47-9.65
Other Non Operating Income (Expenses)
-14.493.36-2.08-2.9-5.180.77
EBT Excluding Unusual Items
1,0671,1611,2411,3251,2421,049
Gain (Loss) on Sale of Investments
-3.41-3.53.610.58-0.03
Gain (Loss) on Sale of Assets
-5.38-4.33-12.2-2.78-1.72-1.17
Asset Writedown
---52.75---
Other Unusual Items
71.9769.21109.0739.9553.0617.54
Pretax Income
1,1301,2231,2891,3631,2941,066
Income Tax Expense
119.52136.3889.82138.41105.0385.69
Earnings From Continuing Operations
1,0111,0861,1991,2241,189979.86
Minority Interest in Earnings
-16.41-18.37-4.78-6.69-21.25-6.19
Net Income
994.141,0681,1941,2171,167973.66
Net Income to Common
994.141,0681,1941,2171,167973.66
Net Income Growth
-13.25%-10.59%-1.89%4.28%19.90%30.20%
Shares Outstanding (Basic)
577571577580584587
Shares Outstanding (Diluted)
577571577580584587
Shares Change
0.73%-1.02%-0.47%-0.68%-0.48%5.10%
EPS (Basic)
1.721.872.072.102.001.66
EPS (Diluted)
1.721.872.072.102.001.66
EPS Growth
-13.88%-9.66%-1.43%5.00%20.48%23.88%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
642.72737.38644.88569.44620.1395.39
Free Cash Flow Per Share
1.111.291.120.981.060.67
Dividend Per Share
1.3101.3101.2601.0520.8000.750
Dividend Growth
3.97%3.97%19.76%31.51%6.67%14.71%
Gross Margin
66.13%64.45%64.61%63.73%58.47%58.98%
Operating Margin
24.22%25.13%25.77%27.15%25.36%25.34%
Profit Margin
23.54%25.27%26.71%27.40%26.28%25.86%
Free Cash Flow Margin
15.22%17.45%14.42%12.81%13.96%10.50%
EBITDA
1,4661,5151,6161,6421,5441,340
EBITDA Margin
34.70%35.85%36.15%36.96%34.76%35.59%
D&A For EBITDA
442.77453.27464.2436.1417.56385.93
EBIT
1,0231,0621,1521,2061,126954.28
EBIT Margin
24.22%25.13%25.77%27.15%25.36%25.34%
Effective Tax Rate
10.58%11.15%6.97%10.16%8.12%8.04%
Revenue as Reported
4,2244,2264,4714,4444,4423,766
Advertising Expenses
-59.5954.3555.7941.445.1